J D Rowley

1.8k total citations
19 papers, 1.5k citations indexed

About

J D Rowley is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, J D Rowley has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Hematology and 5 papers in Oncology. Recurrent topics in J D Rowley's work include Acute Myeloid Leukemia Research (8 papers), Retinoids in leukemia and cellular processes (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). J D Rowley is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Retinoids in leukemia and cellular processes (5 papers) and Acute Lymphoblastic Leukemia research (4 papers). J D Rowley collaborates with scholars based in United States, United Kingdom and Israel. J D Rowley's co-authors include Giuseppina Nucifora, Manuel O. Dı́az, Mark J. Ratain, Michelle M. Le Beau, Robert R. Chilcote, Paula M. Pitha, Stephen D. Smith, Scott C. Fears, Yasuhiko Kaneko and Chantal Mathieu and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

J D Rowley

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J D Rowley United States 13 872 505 271 262 224 19 1.5k
E. J. B. M. Mensink Netherlands 24 728 0.8× 605 1.2× 407 1.5× 276 1.1× 683 3.0× 52 1.9k
Elizabeth Webb Australia 20 1.2k 1.4× 364 0.7× 398 1.5× 102 0.4× 476 2.1× 34 2.0k
P K Pattengale United States 22 572 0.7× 265 0.5× 487 1.8× 132 0.5× 502 2.2× 38 1.6k
Geoffrey R. Kitchingman United States 21 772 0.9× 447 0.9× 427 1.6× 336 1.3× 454 2.0× 46 1.8k
E Tatsumi Japan 21 639 0.7× 313 0.6× 612 2.3× 170 0.6× 685 3.1× 82 1.8k
Niklas Feldhahn United States 21 1.2k 1.4× 256 0.5× 522 1.9× 223 0.9× 642 2.9× 41 2.1k
F Sigaux France 23 515 0.6× 697 1.4× 380 1.4× 386 1.5× 634 2.8× 43 1.7k
Christian Schmidt Germany 17 450 0.5× 241 0.5× 229 0.8× 104 0.4× 401 1.8× 38 1.3k
Ahmad Faili France 18 843 1.0× 148 0.3× 181 0.7× 126 0.5× 915 4.1× 39 1.8k
Katherine Ruffner United States 12 678 0.8× 209 0.4× 823 3.0× 92 0.4× 218 1.0× 31 2.0k

Countries citing papers authored by J D Rowley

Since Specialization
Citations

This map shows the geographic impact of J D Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J D Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J D Rowley more than expected).

Fields of papers citing papers by J D Rowley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J D Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J D Rowley. The network helps show where J D Rowley may publish in the future.

Co-authorship network of co-authors of J D Rowley

This figure shows the co-authorship network connecting the top 25 collaborators of J D Rowley. A scholar is included among the top collaborators of J D Rowley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J D Rowley. J D Rowley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Chen, Jianjun, et al.. (2005). Genome-wide analysis of coordinate expression and evolution of human encoded sense-antisense transcripts. Trends in Genetics. 21(6). 326–329. 112 indexed citations
2.
Dann, Eldad J., et al.. (2000). Lineage specificity of CBFA2 fusion transcripts. Leukemia Research. 24(1). 11–17. 8 indexed citations
3.
Fears, Scott C., Michael C. Gavin, Christopher J. Hetherington, et al.. (1997). Functional characterization of ETV6 and ETV6/CBFA 2 in the regulation of the MCSFR proximal promoter. Proceedings of the National Academy of Sciences. 94(5). 1949–1954. 64 indexed citations
4.
Mathieu, Chantal, David F. Claxton, D E Zhang, et al.. (1996). The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties.. Proceedings of the National Academy of Sciences. 93(3). 1044–1048. 41 indexed citations
5.
Fears, Scott C., Chantal Mathieu, Nancy J. Zeleznik‐Le, et al.. (1996). Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.. Proceedings of the National Academy of Sciences. 93(4). 1642–1647. 175 indexed citations
6.
Rowley, J D. (1994). 1993 American Society of Human Genetics presidential address: can we meet the challenge?. PubMed. 54(3). 403–13. 8 indexed citations
7.
Nucifora, Giuseppina, Catherine R. Begy, Paul A. Erickson, Harry A. Drabkin, & J D Rowley. (1993). The 3;21 translocation in myelodysplasia results in a fusion transcript between the AML1 gene and the gene for EAP, a highly conserved protein associated with the Epstein-Barr virus small RNA EBER 1.. Proceedings of the National Academy of Sciences. 90(16). 7784–7788. 164 indexed citations
8.
Ratain, Mark J. & J D Rowley. (1992). Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genes. Annals of Oncology. 3(2). 107–111. 131 indexed citations
9.
Thangavelu, Maya, Linda A. Snyder, John Anastasi, et al.. (1992). Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donors.. PubMed. 52(17). 4678–81. 12 indexed citations
10.
Rowley, J D, Manuel O. Dı́az, Rafael Espinosa, et al.. (1990). Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome.. Proceedings of the National Academy of Sciences. 87(23). 9358–9362. 215 indexed citations
11.
Rowley, J D. (1988). Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation.. Journal of Clinical Oncology. 6(5). 919–925. 77 indexed citations
12.
Dı́az, Manuel O., Michelle M. Le Beau, Paula M. Pitha, et al.. (1988). Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines.. Proceedings of the National Academy of Sciences. 85(14). 5259–5263. 352 indexed citations
13.
Rowley, J D. (1984). Consistent chromosomal rearrangements in human malignant disease and oncogene location. 508727741–226. 4 indexed citations
14.
Larson, Richard A., Harvey M. Golomb, & J D Rowley. (1981). Chromosome Changes in Hematologic Malignancies. CA A Cancer Journal for Clinicians. 31(4). 222–238. 6 indexed citations
15.
Kaneko, Yasuhiko, et al.. (1981). Interstitial deletion of short arm of chromosome 11 limited to Wilms' tumor cells in a patient without aniridia.. PubMed. 41(11 Pt 1). 4577–8. 105 indexed citations
16.
Rowley, J D. (1980). General report on the second international workshop on chromosomes in leukemia. International Journal of Cancer. 26(5). 531–533. 6 indexed citations
17.
Rowley, J D & Albert de la Chapelle. (1978). General report on the first international workshop on chromosomes in leukemia. International Journal of Cancer. 21(3). 307–308. 12 indexed citations
18.
Rowley, J D, et al.. (1976). Another Variant Translocation in Chronic Myelogenous Leukemia — Revisited. New England Journal of Medicine. 295(16). 900–901. 18 indexed citations
19.
Pergament, Eugene, et al.. (1968). Chromosome mapping of the Duffy blood group locus.. PubMed. 27(4). 216–21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026